The accelerating adoption of electronic health records, e-prescribing and mobile technologies will change the conventions of sample distribution
Applying a consistent framework to choose locations can help optimize R&D and drive cost reduction for pharmaceutical companies of all sizes
To avoid anti-kickback litigation with government, pharma companies need a defensible position on FMV assessments
Technology is enabling more resources to reach the medical affairs teams—in a compliant manner
Examining off-label use of highly prescribed drugs reveals factors that differ from the usual criticism of such usage
'Controlled room temperature' (CRT) shipping is being transformed from standard shipping processes to engineered, compliance-ready processes and materials
Multiple patents contribute to a robust portfolio; however, each patent that issues can potentially become a landmine to another
Evidence Generation Is the Foundation to Optimal Product Positioning
The basic process of defining customer segments and appropriate promotional messaging benefits from a cross-disciplinary approach
Packaging materials have an impact in regulatory compliance, patient safety and drug efficacy
Diving for customer insights through an ocean of crowdsourced data
A collaborative working relationship gives launch day a better chance at success
The trend toward self-administered drugs creates a pressing need for better patient-education resources
Hub services enhance relationships with patients
Better use of available data can add rigor to analyzing managed-markets contracts, thereby allocating rebates / discounts more effectively
Establishing appropriate trade channels is crucial to the launch success of specialty pharmaceuticals
Are you prepared?
Setting a foundation for long-term success: How the pharmaceutical industry can transform Big Data into actionable insight
Personality assessments identify the traits that enable some pharma researchers to ascend to leadership roles in industry
More complex products and higher risk are changing the nature of pharmaceutical outsourcing
The Sharing Conference returns to Baltimore in 2017
Shared-risk or ‘pay for performance’ agreements between drugmakers and payers can represent uncertain rewards for both parties. Use strategic planning before entering into them
Specialty manufacturers have a range of options to consider in how to go to market
Taking stock of lessons learned during pandemic—and opportunities to grow stronger
The case for a single enterprise-wide learning management system
Embracing digital channels and patient-centric strategies has been critical for commercial teams; a review of what some companies have done right
A family-owned pharmaceutical manufacturer plots a 21st-century growth plan